Last reviewed · How we verify

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters (STREAM)

NCT05383274 PHASE4 RECRUITING

Single-arm, prospective study assessing semen quality after treatment with the Optilume Urethral DCB in men between 22 and 65 years of age.

Details

Lead sponsorUrotronic Inc.
PhasePHASE4
StatusRECRUITING
Enrolment34
Start dateMon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionWed Dec 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

United States